Executive Summary
A single massive $124.8M CMS delivery order to Empower AI signals strong federal demand for administrative management consulting in healthcare, with over 60% ($75M) already outlayed securing multi-year revenue through 2027. This bullish award via full competition underscores Empower AI's competitive edge in NAICS 541611 services.
Investors should monitor execution of the remaining $49.7M obligation under firm fixed price terms amid subaward dependencies.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal Professional Services Contracts digest from March 21, 2026.
Investment Signals (1)
- $125M CMS award locks in revenue to 2027 (HIGH)▲
Empower AI secured a $124.8M firm fixed price delivery order (options to $130M) with 60%+ outlayed, providing long-term visibility in federal healthcare consulting.
Risk Flags (1)
- Execution [MEDIUM RISK]▼
Firm fixed price structure exposes Empower AI to cost overruns on remaining $49.7M obligation through 2027; 11 subawards ($9M) add performance variability.
Opportunities (1)
- ◆
Unlock $5.3M in options plus $49.7M remaining obligation through Feb 2027, potentially boosting revenue 4%+ above current obligation.
Sector Themes (1)
- ◆
CMS's large, competed award highlights ongoing need for program evaluation services (PSC R410) amid Medicare/Medicaid priorities.
Watch List (1)
- 👁
{"entity"=>"EMPOWER AI, INC.", "reason"=>"Dominates this period's $125M award; tracks federal revenue concentration and execution.", "trigger"=>"Outlays stalling below 80% by Q4 2026 or new CMS awards"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal Professional Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals